GHO Capital, the European specialist investor in global healthcare, agreed to invest in ClearView Healthcare Partners, a life sciences strategic consultancy. Financial terms were not disclosed. "We are delighted to have the opportunity to partner with the ClearView team. Operating within a highly fragmented market, ClearView is a best-in-class consultancy within the life sciences space. We believe GHO, with its strong sector expertise, is uniquely positioned to build on ClearView’s strong track record and reputation. We look forward to supporting the business in driving international expansion and building out its domain expertise to deliver strategically critical insights to its Biopharma customer base," GHO Capital.